FDA – Page 287 – Pharma.Tips

Tube Leakage Complaint in dental paste filling: sampling and mixing controls for QA review

Investigating Tube Leakage Complaints in Dental Paste Filling: A Practical Approach for QA Review Tube leakage complaints in dental paste filling operations can have significant implications for product quality and…

Assay Oos in dental paste filling: packaging compatibility and shelf-life justification

Investigation of Out-of-Specification Assays in Dental Paste Filling: Ensuring Packaging Compatibility and Shelf-Life Justification In the pharmaceutical manufacturing sector, particularly in the production of dental dosage forms, the emergence of…

Sedimentation Oos during inspection readiness: packaging integrity and stability justification

Addressing Sedimentation OOS during Inspection Readiness: Understanding Packaging Integrity and Stability In the realm of pharmaceutical manufacturing, especially within dosage forms like otic solutions, variations in sedimentation can trigger out-of-specification…

Pet Failure in dental paste filling: GMP investigation steps with CAPA

Addressing Pet Failures in Dental Paste Filling: A Comprehensive GMP Investigation Guide In the fast-paced world of pharmaceutical manufacturing, especially within dental dosage forms, encountering problems like pet failure during…

Content Uniformity Failure after packaging change: sampling and mixing controls for QA review

Addressing Content Uniformity Failures Following a Packaging Change In the dynamic landscape of pharmaceutical manufacturing, maintaining consistency and quality is paramount. A recent case involving a content uniformity failure after…

Ph Drift in dental paste filling: manufacturing vs lab root cause assessment

Root Cause Assessment for pH Drift in Dental Paste Filling: Manufacturing vs Lab Investigation The challenge of pH drift in dental paste filling can lead to significant complications in both…

Sedimentation Oos during inspection readiness: sanitation, water, and EM checks

Investigating Sedimentation OOS during Inspection Readiness: Key Focus Areas for Quality Assurance In the pharmaceutical manufacturing sector, maintaining compliance during inspection readiness is critical, especially concerning out-of-specification (OOS) findings. One…

Content Uniformity Failure after supplier change: sampling and mixing controls for QA review

Investigating Content Uniformity Failures Post-Supplier Change: Strategies for Quality Assurance In the highly regulated environment of pharmaceutical manufacturing, content uniformity (CU) failures can pose significant challenges, particularly following a change…

Tag: FDA

Tube Leakage Complaint in dental paste filling: sampling and mixing controls for QA review

Assay Oos in dental paste filling: packaging compatibility and shelf-life justification

Sedimentation Oos during inspection readiness: packaging integrity and stability justification

Pet Failure in dental paste filling: GMP investigation steps with CAPA

Content Uniformity Failure after packaging change: sampling and mixing controls for QA review

Ph Drift in dental paste filling: manufacturing vs lab root cause assessment

Sedimentation Oos during inspection readiness: sanitation, water, and EM checks

Content Uniformity Failure after supplier change: sampling and mixing controls for QA review

E&L Failure in dental paste filling: GMP investigation steps with CAPA

Phase Separation at accelerated stability: investigation steps with CAPA evidence

Assay Oos at accelerated stability: GMP investigation steps with CAPA

Microbial Limits Failure in dental gel manufacturing: GMP investigation steps with CAPA